Gabapentin Capsules 100mg Cv (Gabapentin 100mg 100s)
Not available*
Gabapentin Capsule
Product Images NDC 68788-8563
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-8563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 01)
Figure 2 (Image 02)
This text appears to describe a study or experiment involving a medication called Gabapentin. There are three dose periods mentioned: a 4-week fixed dose period, a 10-week placebo period, and a 7-week period where the dosage of Gabapentin is increased from 1800 mg/day to 2400 mg/day. The text also mentions a pain score, which starts at a baseline level and is measured over a span of 7 weeks.*
Figure 3 (Image 03)
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
